The team chemically synthesised nearly 300 of the AI-generated genomes and tested them in laboratory conditions, with sixteen of the resulting viruses proving viable.
The Phase 1 study forms part of an expanded collaboration between Moderna and the Coalition for Epidemic Preparedness Innovations (CEPI).
The initiative represents a collaborative effort between JOOTRH, the Kenya Medical Research Institute (KEMRI), and the Liverpool School of Tropical Medicine.